Radioimmunotherapy and radioligandtherapy

LE WE PMID CA

Radioimmunotherapy and radioligandtherapy

6618

Radioimmunotherapie und Radioligandentherapie

Bone marrow transplantation

Neoplasia (Imaging)

Radioimmunotherapy and radioligandtherapy

Structure det. tissue level to single molecule localization

2005 1	The promise of immuno-PET in radioimmunotherapy. [15653665] J Nucl Med 46 Suppl 1(-): 164S-71S (2005)
2005 2	Antibody-based targeted radiation to pediatric tumors. [15653664] J Nucl Med 46 Suppl 1(-): 157S-63S (2005)
2005 3	Current status of therapy of solid tumors: brain tumor therapy. [15653663] J Nucl Med 46 Suppl 1(-): 151S-6S (2005)
2005 4	Current status of therapy of solid tumors. [15653662] J Nucl Med 46 Suppl 1(-): 141S-50S (2005)
2005 5	Tositumomab and (131)I therapy in non-Hodgkin's lymphoma. [15653661] J Nucl Med 46 Suppl 1(-): 128S-40S (2005)
2005 6	Perspectives on cancer therapy with radiolabeled monoclonal antibodies. [15653660] J Nucl Med 46 Suppl 1(-): 115S-27S (2005)
2005 7	Practical dosimetry of peptide receptor radionuclide therapy with (90)Y-labeled somatostatin analogs. [15653657] J Nucl Med 46 Suppl 1(-): 92S-8S (2005)
2005 8	Candidates for peptide receptor radiotherapy today and in the future. [15653654] J Nucl Med 46 Suppl 1(-): 67S-75S (2005)
2005 9	Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs. [15653653] J Nucl Med 46 Suppl 1(-): 62S-6S (2005)
2005 10	MIBG and somatostatin receptor analogs in children: current concepts on diagnostic and therapeutic use. [15653652] J Nucl Med 46 Suppl 1(-): 55S-61S (2005)
2005 11	Bone-seeking radionuclides for therapy. [15653650] J Nucl Med 46 Suppl 1(-): 38S-47S (2005)
2003 12	Molecular targeting with radionuclides: state of the science. [14660721] J Nucl Med 44(12): 1945-61 (2003)
2003 13	Administration guidelines for radioimmunotherapy of non-Hodgkin's lymphoma with 90Y-labeled anti-CD20 monoclonal antibody. [12732690] J Nucl Med 44(5): 853 (2003)
2003 14	Pretargeted radioimmunotherapy of cancer: progress step by step. [12621007] J Nucl Med 44(3): 400-11 (2003)
2002 15	Radioimmunotherapy of B-cell non-Hodgkin's lymphoma: from clinical trials to clinical practice. [12411555] J Nucl Med 43(11): 1507-29 (2002)
2002 16	A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablation. [12411552] J Nucl Med 43(11): 1482-8 (2002)
2002 17	Targeted therapy of cancer with radiolabeled antibodies. [11994535] J Nucl Med 43(5): 693-713 (2002)
2002 18	Administration guidelines for radioimmunotherapy of non-Hodgkin's lymphoma with (90)Y-labeled anti-CD20 monoclonal antibody. [11850494] J Nucl Med 43(2): 267-72 (2002)
2000 19	Peptide receptor imaging and therapy. [11038002] J Nucl Med 41(10): 1704-13 (2000)
1993 20	A ticket to ride: peptide radiopharmaceuticals. [8254420] J Nucl Med 34(12): 2253-63 (1993)
1993 21	Immunoadsorption: an enhancement strategy for radioimmunotherapy. [8509840] J Nucl Med 34(6): 1020-7 (1993)
1982 22	Radioimmunodiagnosis and radioimmunotherapy, 1982. [6180154] J Nucl Med 23(9): 840-50 (1982)
2010 23	Dosimetry for treatment with radiolabelled somatostatin analogues. A review. [20168285] Q J Nucl Med Mol Imaging 54(1): 37-51 (2010)
2007 24	Nuclear imaging in cancer theranostics. [17420716] Q J Nucl Med Mol Imaging 51(2): 152-63 (2007)
2008 25	In vitro receptor binding assays: general methods and considerations. [18475249] Q J Nucl Med Mol Imaging 52(3): 245-53 (2008)
2011 26	Oncologic theranostics: recognition of this concept in antigen-directed cancer therapy for colorectal cancer with anti-TAG-72 monoclonal antibodies. [21902525] Expert Rev Mol Diagn 11(7): 667-70 (2011)
2010 27	Phage display in molecular imaging and diagnosis of cancer. [20170129] Chem Rev 110(5): 3196-211 (2010)
2010 28	Peptides and peptide hormones for molecular imaging and disease diagnosis. [20225899] Chem Rev 110(5): 3087-111 (2010)
2010 29	Multimodality imaging probes: design and challenges. [20225900] Chem Rev 110(5): 3146-95 (2010)
2009 30	Different ways to improve the clinical effectiveness of radioimmunotherapy in solid tumors. [20009292] J Cancer Res Ther 5 Suppl 1(-): S36-40 (2009)
2008 31	Radioimmunotherapy-based conditioning regimens for stem cell transplantation. [18381107] Semin Hematol 45(2): 118-25 (2008)
2006 32	Radioimmunotherapy of B-cell lymphoma with radiolabelled anti-CD20 monoclonal antibodies. [16550338] Clin Exp Med 6(1): 1-12 (2006)
2006 33	Labelling monoclonal antibodies with macrocyclic radiometal complexes. A challenge for coordination chemists. [16865171] Dalton Trans -(30): 3617-23 (2006)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Radioimmunotherapy and radioligandtherapy.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Radioimmunotherapy and radioligandtherapy.php on line 92